Polatuzumab Vedotin-piiq (By injection)
Polatuzumab Vedotin-piiq (pol-a-TOOZ-ue-mab ve-DOE-tin - piiq)
Treats diffuse large B-cell lymphoma (DLBCL).
PolivyThere may be other brand names for this medicine.
When This Medicine Should Not Be Used:
This medicine is not right for everyone. You should not receive it if you had an allergic reaction to polatuzumab vedotin-piiq, or if you are pregnant.
How to Use This Medicine:
- Your doctor will prescribe your dose and schedule. This medicine is given through a needle placed in a vein. This medicine must be given slowly, so the needle will have to stay in place for at least 90 minutes.
- You will receive this medicine while you are in a hospital or cancer treatment center. A nurse or other trained health professional will give you this medicine.
- You may also receive other medicines (including allergy medicine, fever medicine) 30 to 60 minutes before starting treatment with this medicine.
- Missed dose: This medicine needs to be given on a fixed schedule. If you miss a dose, call your doctor, home health caregiver, or treatment clinic for instructions.
Drugs and Foods to Avoid:
Ask your doctor or pharmacist before using any other medicine, including over-the-counter medicines, vitamins, and herbal products.
- Some medicines can affect how polatuzumab vedotin-piiq works. Tell your doctor if you are using ketoconazole or rifampin.
Warnings While Using This Medicine:
- This medicine may cause birth defects if either partner is using it during conception or pregnancy. Tell your doctor right away if you or your partner becomes pregnant. Use an effective form of birth control during treatment with this medicine and for at least 3 months after your last dose. Male patients with female partners should use an effective form of birth control during treatment and for at least 5 months after the last dose.
- Do not breastfeed during treatment with this medicine and for at least 2 months after the last dose.
- Tell your doctor if you have kidney disease, liver disease, nerve problems, or any type of infection.
- This medicine may cause the following problems:
- Peripheral neuropathy (nerve problem)
- Infusion reaction
- Increased risk for serious infections
- Progressive multifocal leukoencephalopathy (brain infection that can be life-threatening)
- Tumor lysis syndrome (electrolyte and metabolic problem that can be life-threatening)
- Liver problems
- Talk with your doctor before using this medicine if you plan to have children. Some men who use this medicine have become infertile (unable to have children).
- This medicine may make you bleed, bruise, or get infections more easily. Take precautions to prevent illness and injury. Wash your hands often.
- Medicines used to treat cancer are very strong and can have many side effects. Before receiving this medicine, make sure you understand all the risks and benefits. It is important for you to work closely with your doctor during your treatment.
- Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments.
Possible Side Effects While Using This Medicine:
Call your doctor right away if you notice any of these side effects:
- Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing
- Dark urine or pale stools, nausea, vomiting, loss of appetite, stomach pain, yellow skin or eyes
- Fever, chills, cough, sore throat, body aches
- Numbness, tingling, or burning pain in your hands, arms, legs, or feet
- Trouble breathing, chest pain
- Unusual bleeding, bruising, or weakness
If you notice these less serious side effects, talk with your doctor:
- Decreased appetite
- Pain, itching, burning, swelling, or a lump under your skin where the needle was placed
If you notice other side effects that you think are caused by this medicine, tell your doctor
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088
Last Updated: 10/10/2019
A.D.A.M. content is best viewed in IE9 or above, Fire Fox and Google Chrome browser.